查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1760731

2025年转录组学全球市场报告

Transcriptomics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年转录组学市场规模将强劲成长。至2029年，该市场规模将成长至96.5亿美元，复合年增长率为8.1%。预测期内，预期增长将受到以下因素的推动：单细胞核糖核酸测序的普及率不断提高、空间转录组学整合度不断提升、对多体学方法的需求不断增长、对疾病早期检测的日益关注以及对非编码核糖核酸重要性的日益认识。预测期内的主要趋势包括：次世代定序(NGS) 技术的进步、空间转录组学的创新、生物资讯工具的改进、机器学习在转录组学中的整合以及即时转录组分析技术的进步。

个人化医疗的日益普及预计将在未来几年推动转录组学市场的成长。个人化医疗是指根据个人的基因组成、生活方式和环境因素制定个人化治疗方案。随着基因序列测定的进步，治疗方案可以根据个人的基因图谱进行定制，从而提高疗效，这种方法正获得越来越多的支持。透过揭示独特的基因表现模式，转录组学可以实现更有效的个人化治疗，减少副作用，并支持疾病的早期诊断。例如，个人化医疗联盟于2024年2月报告称，FDA将在2023年核准16种新的罕见疾病个人化治疗方案。因此，个人化医疗的广泛应用正在促进转录组学市场的成长。

转录组学市场中的公司正专注于开发单细胞空间panel等创新产品，以更深入地了解细胞功能和疾病机制。单细胞空间panel在单一细胞层级分析基因表现，同时保留细胞在组织中的位置。这些panel将单细胞转录组学与空间数据结合，从而深入了解细胞活动和组织结构。例如，2024年2月，NanoString Technologies推出了CosMx 6,000 plex RNA Assay，这是第一个商业性单细胞空间panel，能够测量几乎所有人类生物学通路中超过6,000个RNA靶点。这款突破性产品专为CosMx空间分子成像仪(SMI)设计，使研究人员能够以单细胞和亚细胞分辨率对基因进行高精度和先进的细胞分割分析。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球转录组学 PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球转录组学市场：增长率分析
  • 全球转录组学市场表现：规模与成长，2019-2024
  • 全球转录组学市场预测：2024-2029 年及 2034 年规模与成长
  • 全球转录组学总目标市场（TAM）

第六章市场区隔

  • 全球转录组学市场：依类型、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 装置
  • 耗材
  • 软体
  • 服务
  • 全球转录组学市场（按技术、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 微阵列
  • 即时定量聚合酵素链锁反应
  • 定序技术
  • 全球转录组学市场的应用、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 诊断和疾病分析
  • 药物研发
  • 其他用途
  • 全球转录组学市场：依最终使用者、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 学术研究所
  • 製药公司
  • 生技公司
  • 其他最终用户
  • 全球转录组学市场，依仪器类型细分，绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 微阵列仪器
  • 定序设备
  • 聚合酵素链锁反应（PCR）设备
  • 其他转录组学仪器
  • 全球转录组学市场按耗材类型细分，实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 试剂
  • 探测
  • 套件
  • 洋芋片
  • 全球转录组学市场软体细分（按类型、实际及预测），2019-2024 年、2024-2029 年、2034 年
  • 数据分析软体
  • 资料管理软体
  • 视觉化软体
  • 生物资讯软体
  • 全球转录组学市场，依服务类型细分，绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 数据分析服务
  • 样品製备服务
  • 定序服务
  • 咨询服务

第七章 区域和国家分析

  • 全球转录组学市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球转录组学市场：依国家、表现及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 转录组学市场：竞争格局
  • 转录组学市场：公司简介
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Bio-Rad Laboratories Inc.
  • QIAGEN NV
  • Takara Bio Inc.
  • 10x Genomics Inc.
  • Oxford Nanopore Technologies plc
  • Genewiz Inc.
  • Pacific Biosciences of California Inc.
  • NanoString Technologies Inc.
  • Singleron Biotechnologies
  • SCIEX
  • CD Genomics Inc.
  • Parse Biosciences Inc.
  • Lexogen GmbH
  • LC Sciences LLC
  • Arraystar Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029 年转录组学市场：提供新机会的国家
  • 2029 年转录组学市场：细分领域蕴含新机会
  • 2029 年转录组学市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r35608

Transcriptomics is the study of all ribonucleic acid (RNA) transcripts generated by the genome within a specific cell, tissue, or condition. It aids in deciphering gene expression patterns and regulatory processes, revealing how they change in response to diseases or environmental influences. This field provides valuable insights into cellular functions and disease mechanisms. Transcriptomics plays a key role in biomarker discovery, identifying therapeutic targets, and advancing personalized medicine.

The primary categories of transcriptomics include instruments, consumables, software, and services. Instruments are vital in transcriptomics as they allow for the precise analysis of gene expression through high-throughput sequencing, amplification, and RNA detection. Various technologies are employed, such as microarrays, real-time quantitative polymerase chain reaction, and sequencing technologies. These tools are used for multiple applications, including diagnostics, disease profiling, drug discovery, and others, and are utilized by a wide range of end-users, such as academic and research institutions, pharmaceutical companies, biotechnology firms, and more.

The transcriptomics market research report is one of a series of new reports from The Business Research Company that provides transcriptomics market statistics, including the transcriptomics industry global market size, regional shares, competitors with the transcriptomics market share, detailed transcriptomics market segments, market trends, and opportunities, and any further data you may need to thrive in the transcriptomics industry. This transcriptomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The transcriptomics market size has grown strongly in recent years. It will grow from $6.51 billion in 2024 to $7.06 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth observed in the past can be attributed to an increasing emphasis on personalized medicine, a rising prevalence of cancer, the incorporation of genomics in clinical diagnostics, the expansion of ribonucleic acid sequencing, and a growing demand for biomarker discovery.

The transcriptomics market size is expected to see strong growth in the next few years. It will grow to $9.65 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The expected growth in the forecast period is driven by the rising adoption of single-cell ribonucleic acid sequencing, the increasing integration of spatial transcriptomics, the growing demand for multiomics approaches, a heightened focus on early disease detection, and greater awareness of the significance of non-coding ribonucleic acids. Key trends for the forecast period include advancements in next-generation sequencing (NGS) technologies, innovations in spatial transcriptomics, improvements in bioinformatics tools, the integration of machine learning in transcriptomics, and progress in real-time transcriptomic analysis technologies.

The growing adoption of personalized medicine is expected to drive the growth of the transcriptomics market in the future. Personalized medicine involves customizing treatments based on an individual's genetic makeup, lifestyle, and environmental factors. This approach is gaining traction due to advancements in genetic sequencing, which allow for treatments tailored to a person's genetic profile for greater effectiveness. Transcriptomics helps uncover unique gene expression patterns, enabling personalized treatments that are more effective, reduce side effects, and support early disease diagnosis. For example, in February 2024, the Personalized Medicine Coalition reported that the FDA approved 16 new personalized treatments for rare diseases in 2023, compared to just six in 2022. As a result, the increasing adoption of personalized medicine is contributing to the growth of the transcriptomics market.

Companies in the transcriptomics market are focused on developing innovative products such as single-cell spatial panels to gain deeper insights into cellular functions and disease mechanisms. Single-cell spatial panels analyze gene expression at the individual cell level while preserving the cells' positions within the tissue. These panels combine single-cell transcriptomics with spatial data, providing insights into both cellular activity and tissue structure. For instance, in February 2024, NanoString Technologies launched the CosMx 6,000 plex RNA Assay, the first commercial single-cell spatial panel capable of measuring over 6,000 RNA targets across nearly all human biological pathways. This breakthrough, designed for use with the CosMx Spatial Molecular Imager (SMI), enables researchers to profile genes at single-cell and subcellular resolution with high accuracy and advanced cell segmentation.

In July 2024, Illumina, Inc., a U.S.-based provider of DNA sequencing and array-based technologies, acquired Fluent BioSciences for an undisclosed amount. This acquisition aims to enhance Illumina's multiomics capabilities by integrating Fluent's innovative, scalable single-cell technology, which eliminates the need for complex and expensive equipment. This enables faster, more cost-effective, and comprehensive discoveries in genomics and cell biology. Fluent BioSciences specializes in single-cell analysis technology, a key method in transcriptomics that allows researchers to profile gene expression at the individual cell level.

Major players in the transcriptomics market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Becton Dickinson and Company, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Takara Bio Inc., 10x Genomics Inc., Oxford Nanopore Technologies plc, Genewiz Inc., Pacific Biosciences of California Inc., NanoString Technologies Inc., Singleron Biotechnologies, SCIEX, CD Genomics Inc., Parse Biosciences Inc., Lexogen GmbH, LC Sciences LLC, and Arraystar Inc.

North America was the largest region in the transcriptomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in transcriptomics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the transcriptomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The transcriptomics market consists of revenues earned by entities by providing services such as voice gene expression analysis, ribonucleic acid sequencing, bioinformatics solutions, and data interpretation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The transcriptomics market also includes sales of RNA extraction kits, library preparation kits, and cDNA synthesis kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Transcriptomics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on transcriptomics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for transcriptomics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The transcriptomics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Instruments; Consumables; Software; Services
  • 2) By Technology: Micro Array; Real-Time Quantitative Polymerase Chain Reaction; Sequencing Technologies
  • 3) By Application: Diagnostics And Disease Profiling; Drug Discovery; Other Applications
  • 4) By End-User: Academic And Research Institutes; Pharmaceutical Companies; Biotechnology Companies; Other End-Users
  • Subsegments:
  • 1) By Instruments: Microarray Instruments; Sequencing Instruments; Polymerase Chain Reaction (PCR) Instruments; Other Transcriptomics Instruments
  • 2) By Consumables: Reagents; Probes; Kits; Chips
  • 3) By Software: Data Analysis Software: Data Management Software; Visualization Software: Bioinformatics Software
  • 4) By Services: Data Analysis Services; Sample Preparation Services; Sequencing Services; Consulting Services
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Becton Dickinson and Company; Agilent Technologies Inc.; Illumina Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Transcriptomics Market Characteristics

3. Transcriptomics Market Trends And Strategies

4. Transcriptomics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Transcriptomics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Transcriptomics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Transcriptomics Market Growth Rate Analysis
  • 5.4. Global Transcriptomics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Transcriptomics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Transcriptomics Total Addressable Market (TAM)

6. Transcriptomics Market Segmentation

  • 6.1. Global Transcriptomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Instruments
  • Consumables
  • Software
  • Services
  • 6.2. Global Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Micro Array
  • Real-Time Quantitative Polymerase Chain Reaction
  • Sequencing Technologies
  • 6.3. Global Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostics And Disease Profiling
  • Drug Discovery
  • Other Applications
  • 6.4. Global Transcriptomics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Academic And Research Institutes
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Other End-Users
  • 6.5. Global Transcriptomics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Microarray Instruments
  • Sequencing Instruments
  • Polymerase Chain Reaction (PCR) Instruments
  • Other Transcriptomics Instruments
  • 6.6. Global Transcriptomics Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Reagents
  • Probes
  • Kits
  • Chips
  • 6.7. Global Transcriptomics Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Data Analysis Software
  • Data Management Software
  • Visualization Software
  • Bioinformatics Software
  • 6.8. Global Transcriptomics Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Data Analysis Services
  • Sample Preparation Services
  • Sequencing Services
  • Consulting Services

7. Transcriptomics Market Regional And Country Analysis

  • 7.1. Global Transcriptomics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Transcriptomics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Transcriptomics Market

  • 8.1. Asia-Pacific Transcriptomics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Transcriptomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Transcriptomics Market

  • 9.1. China Transcriptomics Market Overview
  • 9.2. China Transcriptomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Transcriptomics Market

  • 10.1. India Transcriptomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Transcriptomics Market

  • 11.1. Japan Transcriptomics Market Overview
  • 11.2. Japan Transcriptomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Transcriptomics Market

  • 12.1. Australia Transcriptomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Transcriptomics Market

  • 13.1. Indonesia Transcriptomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Transcriptomics Market

  • 14.1. South Korea Transcriptomics Market Overview
  • 14.2. South Korea Transcriptomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Transcriptomics Market

  • 15.1. Western Europe Transcriptomics Market Overview
  • 15.2. Western Europe Transcriptomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Transcriptomics Market

  • 16.1. UK Transcriptomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Transcriptomics Market

  • 17.1. Germany Transcriptomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Transcriptomics Market

  • 18.1. France Transcriptomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Transcriptomics Market

  • 19.1. Italy Transcriptomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Transcriptomics Market

  • 20.1. Spain Transcriptomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Transcriptomics Market

  • 21.1. Eastern Europe Transcriptomics Market Overview
  • 21.2. Eastern Europe Transcriptomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Transcriptomics Market

  • 22.1. Russia Transcriptomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Transcriptomics Market

  • 23.1. North America Transcriptomics Market Overview
  • 23.2. North America Transcriptomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Transcriptomics Market

  • 24.1. USA Transcriptomics Market Overview
  • 24.2. USA Transcriptomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Transcriptomics Market

  • 25.1. Canada Transcriptomics Market Overview
  • 25.2. Canada Transcriptomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Transcriptomics Market

  • 26.1. South America Transcriptomics Market Overview
  • 26.2. South America Transcriptomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Transcriptomics Market

  • 27.1. Brazil Transcriptomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Transcriptomics Market

  • 28.1. Middle East Transcriptomics Market Overview
  • 28.2. Middle East Transcriptomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Transcriptomics Market

  • 29.1. Africa Transcriptomics Market Overview
  • 29.2. Africa Transcriptomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Transcriptomics Market Competitive Landscape And Company Profiles

  • 30.1. Transcriptomics Market Competitive Landscape
  • 30.2. Transcriptomics Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Transcriptomics Market Other Major And Innovative Companies

  • 31.1. Bio-Rad Laboratories Inc.
  • 31.2. QIAGEN N.V.
  • 31.3. Takara Bio Inc.
  • 31.4. 10x Genomics Inc.
  • 31.5. Oxford Nanopore Technologies plc
  • 31.6. Genewiz Inc.
  • 31.7. Pacific Biosciences of California Inc.
  • 31.8. NanoString Technologies Inc.
  • 31.9. Singleron Biotechnologies
  • 31.10. SCIEX
  • 31.11. CD Genomics Inc.
  • 31.12. Parse Biosciences Inc.
  • 31.13. Lexogen GmbH
  • 31.14. LC Sciences LLC
  • 31.15. Arraystar Inc.

32. Global Transcriptomics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Transcriptomics Market

34. Recent Developments In The Transcriptomics Market

35. Transcriptomics Market High Potential Countries, Segments and Strategies

  • 35.1 Transcriptomics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Transcriptomics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Transcriptomics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer